Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavain Sweetman

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|February 17, 2018
Systematic analysis of protein turnover in primary cellsToby Mathieson, Holger Franken, Jan Kosinski, et al.
Nature Biotechnology|August 28, 2007
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsMarcus Bantscheff, Dirk Eberhard, Yann Abraham, et al.
Nature Biotechnology|January 25, 2011
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesMarcus Bantscheff, Carsten Hopf, Mikhail M Savitski, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|February 17, 2018
Systematic analysis of protein turnover in primary cellsToby Mathieson, Holger Franken, Jan Kosinski, et al.
Nature Biotechnology|August 28, 2007
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsMarcus Bantscheff, Dirk Eberhard, Yann Abraham, et al.
Nature Biotechnology|January 25, 2011
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesMarcus Bantscheff, Carsten Hopf, Mikhail M Savitski, et al.
Pageof 2